Literature DB >> 74629

Oral contraceptives and cholangiocarcinoma.

E F Ellis, P R Gordon, L S Gottlieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 74629     DOI： 10.1016/s0140-6736(78)90640-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

Authors:  S D Taylor-Robinson; M B Toledano; S Arora; T J Keegan; S Hargreaves; A Beck; S A Khan; P Elliott; H C Thomas
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma.

Authors:  Wen-Liang Wang; Guang-Yu Gu; Min Hu
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

Review 3.  Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.

Authors:  Tarun Rustagi; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2012-06

4.  Demographic and clinicopathological Profile of Gall Bladder Cancer Patients: Study from a tertiary care center of the Sub-Himalayan region in Indo-Gangetic Belt.

Authors:  Amit Gupta; Sweety Gupta; Rohik Anjum T Siddeek; Jaine John Chennatt; Tanuj Singla; Deepak Rajput; Navin Kumar; Amit Sehrawat; Sanjeev Kishore; Manoj Gupta
Journal:  J Carcinog       Date:  2021-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.